Replication and Integration of HPV in Cervical Cancers

Project: Research project

Project Details


DESCRIPTION (provided by applicant) In this renewal FIRCA application, we propose to examine the changes in cellular gene expression that occur during progression to malignancy in HPV-positive cancers. This is a joint proposal from the Laboratory of Tumor Transforming Proteins of the Cancer Research Center in Moscow Russia and the laboratory of Dr. Laimonis A. Laimins at Northwestern University in Chicago, IL. These studies are complementary to the aims of the parental NIH grant (CA59655) awarded to Dr. Laimins entitled "Regulation of Papillomavirus Gene Expression". In our recently completed studies supported by a FIRCA grant, we determined that approximately 50% of HPV-16 positive anogenital tumors contain exclusively episomal forms of expressed HPV DNA. The remainder contains either exclusively integrated forms or a combination of both. It was further determined that integration into host sequences was random and that there was no specific sequences at the sites of integration. While some mutations were identified in the URR, Et and E2 open reading frames, no correlation of mutation with integration was found. For this renewal application we will focus on the changes in cellular gene expression that are induced by HPV gene products and investigate how these may contribute to malignant conversion. For these studies the Moscow groups will examine already available frozen tumor samples from patients at various progressive stages of HPV-induced cancers. To insure homogeneity of cell types, tumor cells will be isolated by laser capture microdissection, a process at which the Moscow group is very skilled. The Moscow group will then examine changes in gene expression. Using these methods we will ask the following: 1). Are changes in cellular gene expression seen in microarray analyses of HPV tumor cell lines also detected in a variety of tumors at various stages in vivo? Are these changes seen at multiple stages of progression? 2). What changes in gene expression as det
Effective start/end date5/1/044/30/07


  • John E. Fogarty International Center for Advanced Study in the Health Sciences (5 R03 TW001353-06)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.